Enrique Salem

About Enrique Salem

Enrique Salem (age 59) is an independent Class III director at Docusign, serving since August 2013, and a partner at Bain Capital Ventures since July 2014; he previously served as President, CEO, and COO of Symantec (now Gen Digital) and holds an A.B. in Computer Science from Dartmouth College . His board-level expertise spans cybersecurity, finance, risk management, and governance; the Board has determined he is independent under Nasdaq standards .

Past Roles

Organization	Role	Tenure	Committees/Impact
Symantec (Gen Digital)	President, CEO, COO	Prior to 2014 (not specified)	Senior leadership in cybersecurity operations
Bain Capital Ventures	Partner	Since July 2014	Early-stage infra software/cyber specialist; broad investor network

External Roles

Organization	Role	Tenure	Committees/Impact
Rubrik, Inc.	Director	Current (as of 2025)	Member, Nominating & Corporate Governance Committee
Atlassian Corporation	Director (retired)	2013–Apr 2025	Audit and Nominating Committee member; retired April 14, 2025
FireEye, Inc. (prior)	Director	Prior service (not current)	Cybersecurity oversight
ForeScout Technologies, Inc. (prior)	Director	Prior service (not current)	Network security oversight

Board Governance

Committee assignments: Audit Committee member; Audit Committee composition includes Chair Teresa Briggs, and members James Beer, Enrique Salem, and Anna Marrs; each member deemed independent, “financially sophisticated,” and an “audit committee financial expert” .
Independence: The Board determined Salem is independent under SEC/Nasdaq rules; 8 of 9 continuing directors are independent .
Attendance: The Board met 24 times in FY25; each director attended at least 75% of aggregate Board and committee meetings; all continuing directors attended the 2024 Annual Meeting .
Risk oversight: The Audit Committee oversees financial reporting, internal controls, compliance, and cybersecurity risk; management provides regular cyber updates to the Board/Audit Committee .

Fixed Compensation

Component	Amount/Terms	FY25 Salem
Cash Retainer	$46,500 annual	$46,500
Committee Fees	Audit Committee non-chair: $15,000 annual	$15,000
Chair/Lead Fees	Not applicable (not Chair/Lead)	$0
Meeting Fees	Not listed in policy	$0 (not disclosed)
Equity – Annual RSU	Target $250,000 grant-date fair value, vests quarterly; accelerates on change-in-control	Stock awards recognized: $249,971
Total FY25 Director Comp	Cash + Equity	$311,471 total; $61,500 cash; $249,971 equity

Notes: Non-employee director RSUs are granted on the Annual Meeting date and generally vest in four equal quarterly installments; all annual grants vest in full upon change-of-control .

Performance Compensation

Performance-Based Component	Terms	FY25 Salem
PSUs/Performance Metrics for Directors	None; non-employee director compensation comprises cash fees and time-based RSUs (no performance conditions)	Not applicable

Other Directorships & Interlocks

Bain Capital Ventures role: Salem is a BCV partner; BCV entities hold significant positions in various technology companies (e.g., Rubrik); BCV governance is directed by BCVI’s Executive Committee (Salem is a member), indicating broad network interlocks but none disclosed as related-party at Docusign .
No Docusign related-party transactions involving Salem disclosed since Feb 1, 2024; a disclosed transaction involved Jackson Square Ventures/Director Peter Solvik (OneNotary financing), not Salem .

Expertise & Qualifications

Cybersecurity/information security expertise; identified in Board skills matrix; prior Symantec CEO/COO enhances oversight of cyber risk and enterprise-scale operations .
Finance and risk management experience; Audit Committee financial expert designation supports effectiveness in financial oversight .
Governance: prior public company board experience and committee service (Audit, Nominating) across multiple companies .
Education: A.B. in Computer Science (Dartmouth) .

Equity Ownership

Metric	Value	Notes
Total Beneficial Ownership (DOCU common)	163,333 shares	<1% of shares outstanding
Shares Subject to Outstanding RSUs	2,137 shares	As of Jan 31, 2025
Options Outstanding	0	None disclosed
Ownership Guidelines (Directors)	3.0x annual Board retainer	Applies to all non-employee directors
Compliance Status	Met or within allowed time	As of Jan 31, 2025, all non-employee directors met or had time to meet guidelines
Hedging/Pledging Policy	Prohibited	Short sales, hedging, pledging, margin accounts prohibited

Governance Assessment

Strengths:
- Independence and financial expertise on Audit Committee (Salem designated audit committee financial expert), strengthening oversight of reporting, controls, and cybersecurity .
- Attendance and engagement: Board met 24 times in FY25; directors attended ≥75%, indicating active oversight; Salem participated in committee reports included in the proxy .
- Alignment policies: Mandatory stock ownership guidelines (3x retainer) with compliance or timeline adherence as of Jan 31, 2025; prohibition on hedging/pledging enhances alignment with shareholders .
- No related-party transactions involving Salem disclosed; Docusign maintains formal related person transaction policy administered by the Audit Committee .
Potential considerations/monitoring:
- Venture interlocks: As a BCV partner and director at Rubrik (and prior at Atlassian), monitor any prospective transactions between Docusign and BCV portfolio companies for independence and related-party review; Docusign policy clarifies when director-affiliated entities are considered related persons and requires Audit Committee review where applicable .
- Classified board structure persists (Board concluded appropriate for size/tenure/industry), but investors may prefer declassification; continued engagement and rationale disclosure are ongoing .
Red flags:
- None disclosed for Salem regarding conflicts, related-party transactions, hedging/pledging, or attendance; director compensation is standard (cash retainer + committee fee + annual RSUs) with no unusual guarantees or option repricings .